Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The Food and Drug Administration on Wednesday approved Kite Pharma's gene therapy, Yescarta, which uses patients' genetically modified immune cells to fight cancer.
Novartis will eliminate 450 U.S. jobs over the next two years during the gradual closure of its generic drug manufacturing plant in Broomfield, Colo., reports Reuters.
The No. 1 attribute providers ranked as important when purchasing a medical device is consistent outcomes, according to a Vennli survey.
The price of injectable brand-name cancer drugs are rising at a pace faster than inflation, according to a study published in the Journal of Clinical Oncology.
Minnetonka, Minn.-based UnitedHealth Group sees Amazon, who is reportedly exploring entering the pharmaceutical business, as a potential partner rather than a competitor, reports The Star Tribune.
The Food and Drug Adminstration on Wednesday granted market clearance to OptiScan Biomedical Corp.'s OptiScanner 5000 Glucose Monitoring System for use in the surgical intensive care unit.
Drug companies produce eye drops at a size much larger than the human eye can hold, reports ProPublica.
The Food and Drug Administration on Monday granted market clearance to Stryker's cementless knee implant.
Amneal Pharmaceuticals and Impax Laboratories will combine to form the fifth largest generics business in the country, based on revenue.
The United Kingdom and European Union have yet to reach a trade deal for medications ahead of Britain's 2019 exit from the EU, according to Bloomberg.